Updates on Anti-Cancer Drug Research

Dear Colleagues,

We announce a Special Issue dedicated to the latest advancements in anti-cancer drug research. As the understanding of cancer biology deepens, innovative approaches have become increasingly pivotal in identifying novel therapeutic targets, predicting drug responses, and overcoming resistance mechanisms.

This Special Issue will showcase cutting-edge research that enhances the development and efficacy of anti-cancer therapies. We invite researchers to submit original research articles and reviews that provide new insights into mechanistic studies, technological innovations, and clinical applications to refine cancer treatment strategies. This Special Issue will serve as a comprehensive resource for scientists and clinicians interested in integrating molecular biology and pharmacology to target and treat cancer more effectively.

Examples of anticipated, but non-exhaustive, submission topics are as follows:

• Gene expression profiling in drug-resistant cancers;
• Predictive biomarkers;
• Impacts of epigenetic modifications on drug response;
• Immune checkpoint inhibitors;
• Novel computational approaches for analyzing gene expression in cancer;
• Tumor microenvironments during therapy;
• Pharmacogenomics and personalized medicine in cancer treatment.

Dr. Ana Luísa De Sousa-Coelho
Dr. Mónica Fernandes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.